We are live on
!
Find out more
TCM
Timpani Capital Management Portfolio holdings
AUM
$209M
1-Year Est. Return
62.15%
This Fund
S&P 500
This Quarter
Est. Return
+16.76%
1 Year Est. Return
+62.15%
3 Year Est. Return
+383.19%
5 Year Est. Return
+934.71%
10 Year Est. Return
–
AUM
$269M
AUM Growth
+$19.9M
(+8%)
Cap. Flow
-$10.7M
Cap. Flow
% of AUM
-3.98%
Top 10 Holdings %
Top 10 Hldgs %
20.39%
Holding
121
New
26
Increased
30
Reduced
38
Closed
27
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AMED
Amedisys
AMED
|
+$4.57M |
| 2 |
Merit Medical Systems
MMSI
|
+$3.79M |
| 3 |
Tactile Systems Technology
TCMD
|
+$3.38M |
| 4 |
Pacira BioSciences
PCRX
|
+$3.37M |
| 5 |
BFYT
Benefytt Technologies, Inc. Class A Common Stock
BFYT
|
+$3.12M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
COHR
Coherent Inc
COHR
|
+$5.1M |
| 2 |
NUVA
NuVasive, Inc.
NUVA
|
+$4.57M |
| 3 |
Quanta Services
PWR
|
+$4.3M |
| 4 |
STMP
Stamps.com, Inc.
STMP
|
+$4.16M |
| 5 |
WIX.com
WIX
|
+$3.92M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.48% |
| 2 | Healthcare | 25.82% |
| 3 | Industrials | 13.44% |
| 4 | Consumer Discretionary | 7.72% |
| 5 | Consumer Staples | 7.36% |
Similar funds
UIM
CI
CWM
BA
TAM
HAM
EMR
NAP
Timpani Capital Management's Q2 2017 Portfolio in Review
As of Q2 2017, Timpani Capital Management held 121 positions worth $269M, up 8% from $250M the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Timpani Capital Management withdrew a net $10.7M in Q2 2017, closing 27 positions and reducing 38 holdings. Its most notable exit was NuVasive, Inc., an estimated $4.57M position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Timpani Capital Management opened a new position in Amedisys worth $4.92M.
- Timpani Capital Management's largest Q2 2017 buy was Amedisys: 78,401 shares worth $4.92M.
- Timpani Capital Management added most to Addus HomeCare in Q2 2017, an estimated $2.71M increase.
- Timpani Capital Management's biggest Q2 2017 reduction was Coherent Inc, cutting an estimated $5.1M.
- Timpani Capital Management fully exited NuVasive, Inc. in Q2 2017, selling an estimated $4.57M.
- Timpani Capital Management's ten largest holdings make up 20% of its $269M portfolio in Q2 2017.
- Timpani Capital Management opened 26 new positions and closed 27 in Q2 2017.
- Timpani Capital Management's portfolio value rose 8% quarter-over-quarter to $269M.
Based on Timpani Capital Management's 13F filing for Q2 2017, filed 10 Aug 2017.